Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology, Others), By End User (Hospitals, Diagnostic Centers, Cancer Re

Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology, Others), By End User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology, Others), By End User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


Radioactive tracers have become an essential tool in several industries, including healthcare, research, and oil exploration. These tracers consist of radioactive substances that emit radiation, which can be easily detected and measured. They are used to track the movement of specific molecules, study various biological processes, and identify potential sources of underground reserves. The global radioactive tracer market has witnessed significant growth in recent years, owing to the increasing applications of radioactive tracers in medical diagnostics and treatment, as well as in the environmental and petrochemical sectors.

Market Dynamics:

The radioactive tracer market is driven by several factors, including technological advancements, increasing prevalence of chronic diseases, and the growing demand for personalized medicine. The market is witnessing significant growth due to the rising adoption of diagnostic imaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), which utilize radioactive tracers to detect and analyze various diseases and conditions.

On the other hand, the market faces certain challenges, such as stringent regulations related to the use and disposal of radioactive substances. Regulatory bodies impose strict guidelines to ensure the safe handling and disposal of radioactive tracers, which significantly increases the cost of production and affects market growth. Additionally, the limited availability of skilled professionals and the high cost associated with nuclear medicine procedures are expected to restrain market growth to some extent.

Despite these challenges, the radioactive tracer market is filled with opportunities for growth. Advancements in radiopharmaceutical manufacturing techniques and the development of new radioactive isotopes are expected to create new avenues for market players. Moreover, the increasing adoption of radioactive tracers in industries such as oil and gas exploration, environmental monitoring, and industrial testing is anticipated to drive market growth further.

Key features of the study:
  • This report provides in-depth analysis of the global radioactive tracer market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global radioactive tracer market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include PerkinElmer, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, NTP Radioisotopes, JSC Isotope, ANSTO, Nordion, Curium Pharma, and IRE
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global radioactive tracer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radioactive tracer market
Detailed Segmentation:
  • By Type
  • Diagnostic Radioactive Tracers
  • Therapeutic Radioactive Tracers
  • Others
  • By Application
  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Lymphoma
  • Endocrinology
  • Others
  • By End User
  • Hospitals
  • Diagnostic Centers
  • Cancer Research Institutes
  • Others
  • By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Top companies in Radioactive Tracer Market:
  • PerkinElmer
  • Cardinal Health
  • Lantheus Medical Imaging
  • Bracco Imaging
  • NTP Radioisotopes
  • JSC Isotope
  • ANSTO
  • Nordion
  • Curium Pharma
  • IRE


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing prevalence of chronic diseases
Short half-life of radiopharmaceuticals
Emerging applications in oncology
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Radioactive Tracer Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Radioactive Tracer Market , By Type, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Diagnostic Radioactive Tracers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Therapeutic Radioactive Tracers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Radioactive Tracer Market , By Application, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Cardiology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Thyroid
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Endocrinology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Radioactive Tracer Market , By End User, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Cancer Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Radioactive Tracer Market , By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
9. Competitive Landscape
PerkinElmer
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Cardinal Health
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Lantheus Medical Imaging
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bracco Imaging
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
NTP Radioisotopes
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
JSC Isotope
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
ANSTO
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Nordion
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Curium Pharma
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
IRE
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on “Radioactive Tracer Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings